Constance Mao

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study
    Constance Mao
    Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98104 2499, USA
    Int J Cancer 120:2435-8. 2007
  2. ncbi Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia
    Tiffany G Harris
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Am J Epidemiol 159:834-42. 2004
  3. ncbi Evaluation of an ELISA for p16INK4a as a screening test for cervical cancer
    Akhila Balasubramanian
    Department of Epidemiology, University of Washington, Seattle, Washington, USA
    Cancer Epidemiol Biomarkers Prev 18:3008-17. 2009
  4. ncbi Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3
    Long Fu Xi
    Department of Pathology, School of Medicine, University of Washington, 1914 North 34th St, Suite 300, Seattle, WA 98103, USA
    J Natl Cancer Inst 101:153-61. 2009
  5. ncbi Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States
    Janet G Baseman
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Am J Obstet Gynecol 199:26.e1-8. 2008
  6. ncbi Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up
    Long Fu Xi
    Department of Pathology, School of Medicine, University of Washington, Seattle, USA
    J Infect Dis 200:1789-97. 2009
  7. ncbi Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral
    Shalini L Kulasingam
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    JAMA 288:1749-57. 2002
  8. ncbi Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples
    Akhila Balasubramanian
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    J Low Genit Tract Dis 14:185-95. 2010
  9. ncbi Clinical findings among young women with genital human papillomavirus infection
    Constance Mao
    Department of Obstetrics and Gynecology, University of Washington, Seattle, USA
    Am J Obstet Gynecol 188:677-84. 2003
  10. ncbi Should liquid-based cytology be repeated at the time of colposcopy?
    Constance Mao
    Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA
    J Low Genit Tract Dis 9:82-8. 2005

Detail Information

Publications16

  1. ncbi Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study
    Constance Mao
    Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98104 2499, USA
    Int J Cancer 120:2435-8. 2007
    ..These findings support proceeding with a larger study with samples from a population of women presenting for routine cytology screening...
  2. ncbi Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia
    Tiffany G Harris
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Am J Epidemiol 159:834-42. 2004
    ..Since smoking was associated with both CIN1 and >/= CIN2-3, cigarette by-products may affect the early evolution of HPV-related lesions, possibly by increasing the rate of cell turnover...
  3. ncbi Evaluation of an ELISA for p16INK4a as a screening test for cervical cancer
    Akhila Balasubramanian
    Department of Epidemiology, University of Washington, Seattle, Washington, USA
    Cancer Epidemiol Biomarkers Prev 18:3008-17. 2009
    ..The low sensitivity of cytology and low specificity of human papillomavirus testing prompts searching for more accurate cervical cancer screening strategies. Our goal was to evaluate an ELISA-based test for p16(INK4a)...
  4. ncbi Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3
    Long Fu Xi
    Department of Pathology, School of Medicine, University of Washington, 1914 North 34th St, Suite 300, Seattle, WA 98103, USA
    J Natl Cancer Inst 101:153-61. 2009
    ..The clinical relevance of the amount of human papillomavirus type 18 (HPV18) DNA in cervical tissue (ie, HPV18 DNA load) is unknown...
  5. ncbi Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States
    Janet G Baseman
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Am J Obstet Gynecol 199:26.e1-8. 2008
    ....
  6. ncbi Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up
    Long Fu Xi
    Department of Pathology, School of Medicine, University of Washington, Seattle, USA
    J Infect Dis 200:1789-97. 2009
    ..Studies of viral load-associated persistence of human papillomavirus (HPV) infection are rare, with inconsistent results reported...
  7. ncbi Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral
    Shalini L Kulasingam
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    JAMA 288:1749-57. 2002
    ..In some settings, particularly where screening intervals are long or haphazard, screening for HPV DNA may be a reasonable alternative to cytology-based screening of reproductive-age women...
  8. ncbi Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples
    Akhila Balasubramanian
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    J Low Genit Tract Dis 14:185-95. 2010
    ..Estimate the accuracy and cost-effectiveness of cervical cancer screening strategies based on high-risk human papillomavirus (HPV) DNA testing of self-collected vaginal samples...
  9. ncbi Clinical findings among young women with genital human papillomavirus infection
    Constance Mao
    Department of Obstetrics and Gynecology, University of Washington, Seattle, USA
    Am J Obstet Gynecol 188:677-84. 2003
    ..Furthermore, a time lag analysis suggests that HPV infection usually precedes detection of BV. CONCLUSION: Most women who acquire genital HPV infection are asymptomatic; some, however, are at increased risk for BV...
  10. ncbi Should liquid-based cytology be repeated at the time of colposcopy?
    Constance Mao
    Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA
    J Low Genit Tract Dis 9:82-8. 2005
    ..To evaluate the usefulness of repeated liquid cytology at the time of colposcopy...
  11. ncbi Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR
    Mingjun Jiang
    Department of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA
    J Clin Microbiol 47:521-6. 2009
    ....
  12. ncbi p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types
    S Nicholas Agoff
    Department of Pathology, University of Washington, Seattle, Washington 98195, USA
    Mod Pathol 16:665-73. 2003
    ..Although expression of p16(INK4a) in endometrial epithelium may be problematic in terms of screening, the potential of p16(INK4a) as a screening test warrants investigation...
  13. ncbi Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine
    Ali Rowhani-Rahbar
    Department of Epidemiology, University of Washington, Seattle, WA 98125, USA
    Vaccine 27:5612-9. 2009
    ..The results suggest that this monovalent HPV-16 vaccine remains efficacious through 8.5 years after its administration...
  14. ncbi Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial
    Constance Mao
    Department of Obstetrics and Gynecology and Epidemiology, University of Washington, Seattle, Washington 98104 2499, USA
    Obstet Gynecol 107:18-27. 2006
    ..Whether protection lasts longer than 18 months and, thus, impacts rates of cervical intraepithelial neoplasia (CIN) 2-3 has not yet been established. We present results from an HPV16 L1 VLP vaccine trial through 48 months...
  15. ncbi Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry?
    Atar Baer
    Department of Epidemiology, University of Washington, Seattle, Washington 98103, USA
    Obstet Gynecol 99:1053-9. 2002
    ..Based upon our data, we do not recommend repeat screening of reproductive-aged women with negative liquid-based tests and no cytologic evidence of a transformation zone component...
  16. ncbi Teaching residents humanistic skills in a colposcopy clinic
    Constance Mao
    Department of Obstetrics and Gynecology, University of Washington, Seattle, 98103, USA
    Acad Med 77:742. 2002
    ..To document the curriculum's effect on patient satisfaction and care, we plan to pilot the use of a patient survey regarding physicians' humanistic qualities...